EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Establishing Glycemic Targets

Diana Soliman, Ron T Varghese, Guillermo E Umpierrez, Rodolfo J Galindo

Medical Clinics of North America · 2025

DOI: 10.1016/j.mcna.2025.11.006 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Clinics of North America, 2025. Verfasst von Diana Soliman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Department of Internal Medicine, University of Miami Miller School of Medicine, 1450 Northwest 10th Avenue, Miami, FL 3313…. Hauptthemen laut MEDLINE: Blood Glucose, Hyperglycemia, Hypoglycemic Agents, Glycemic Control. Die Arbeit nennt 79 Literaturangaben. Gefördert von: Bayer, National Institutes of Health, Abbott Laboratories.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysglycemia in hospitalized patients, including hyperglycemia, hypoglycemia, and glycemic variability, is associated with adverse clinical outcomes and increased health care utilization. Evidence from landmark trials in critically ill patients supports moderate glycemic targets (140-180 mg/dL) over intensive control. Basal-bolus regimens improve outcomes compared to sliding scale insulin alone in noncritically ill settings. However, limited studies have compared glycemic targets in the noncritically ill hospitalized population. Emerging data support the use of continuous glucose monitoring and diabetes technology in the inpatient setting. Current guidelines emphasize individualized and protocol-driven management to optimize inpatient care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood GlucoseHyperglycemiaHypoglycemic AgentsGlycemic ControlHypoglycemiaDiabetes MellitusHumansContinuous Glucose MonitoringInsulinHospitalization

Stichwörter der Autor:innen

Basal-bolus insulinContinuous glucose monitoringDiabetes technologyHyperglycemiaHypoglycemiaInpatient glycemic management

Substanzen

Blood GlucoseHypoglycemic AgentsInsulin

Autor:innen und Institutionen

  • Division of Endocrinology, Department of Internal Medicine, University of Miami Miller School of Medicine, 1450 Northwest 10th Avenue, Miami, FL 33136, USA. Electronic address: dsoliman@med.miami.edu.
  • Division of Endocrinology, Department of Internal Medicine, Sleep - Endocrinology Clinic, University of Miami Miller School of Medicine, 1450 Northwest 10th Avenue, Miami, FL 33136, USA.
  • Division of Endocrinology, Department of Medicine, Emory University School of Medicine, 69 Jesse Hill Jr Drive, Atlanta, GA 30309, USA.
  • Division of Endocrinology, Department of Internal Medicine, University of Miami Miller School of Medicine, 1450 Northwest 10th Avenue, Miami, FL 33136, USA.

Förderung

  • Bayer
  • National Institutes of Health
  • Abbott Laboratories
  • National Center for Research Resources
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Soliman, D., Varghese, R. T., Umpierrez, G. E., & Galindo, R. J. (2025). Establishing Glycemic Targets. Medical Clinics of North America. https://doi.org/10.1016/j.mcna.2025.11.006

Vancouver

Soliman D, Varghese RT, Umpierrez GE, Galindo RJ. Establishing Glycemic Targets. Medical Clinics of North America. 2025. doi:10.1016/j.mcna.2025.11.006

BibTeX
@article{Soliman2025,
  author = {Soliman, Diana and Varghese, Ron T and Umpierrez, Guillermo E and Galindo, Rodolfo J},
  title = {Establishing Glycemic Targets},
  journal = {Medical Clinics of North America},
  year = {2025},
  doi = {10.1016/j.mcna.2025.11.006}
}
Kostenlos starten →